Item 16. Form 10-K Summary.

3K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

McKESSON CORPORATION

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


									McKESSON CORPORATION

May 7, 2026									/s/ Britt J. Vitalone
									Britt J. Vitalone
									Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated:


/s/ Brian S. Tyler						/s/ Julie L. Gerberding, M.D., M.P.H.
Brian S. Tyler Chief Executive Officer and Director (Principal Executive Officer)						Julie L. Gerberding, M.D., M.P.H., Director

/s/ Britt J. Vitalone						/s/ James H. Hinton
Britt J. Vitalone Executive Vice President and Chief Financial Officer (Principal Financial Officer)						James H. Hinton, Director

/s/ Napoleon B. Rutledge Jr.						/s/ Donald R. Knauss
Napoleon B. Rutledge Jr. Senior Vice President and Controller (Principal Accounting Officer)						Donald R. Knauss, Director

/s/ Dominic J. Caruso						/s/ Bradley E. Lerman
Dominic J. Caruso, Director						Bradley E. Lerman, Director

/s/ Lynne M. Doughtie						/s/ Maria N. Martinez
Lynne M. Doughtie, Director						Maria N. Martinez, Director

/s/ W. Roy Dunbar						/s/ Kevin M. Ozan
W. Roy Dunbar, Director						Kevin M. Ozan, Director

/s/ Deborah Dunsire, M.D.						/s/ Kathleen Wilson-Thompson
Deborah Dunsire, M.D., Director						Kathleen Wilson-Thompson, Director

May 7, 2026

Previous: Item 15. Exhibits and Financial Statement Schedule.